PI3K/AKT and STAT3 pathways mediate the neuroprotective effect of dasatinib from acute cerebral injury in endotoxemic mice
Abstract
Background and purpose: Sepsis induces brain dysfunction and there is still a requirement for an unemployed viable restorative approach. This study aimed to investigate the role of dasatinib in the modulation of proinflammatory mediators, attenuating neuroinflammatory response, and it's signaling pathway during endotoxemia.
Experimental approach: Twenty-four adult male Swiss-albino mice were randomized into four groups: sham (undergo laparotomy without cecal ligation and puncture, sepsis (laparotomy with cecal ligation and puncture), vehicle-dimethyl sulfoxide, dasatinib (20 mg/kg/day) intraperitoneally. Brain tissue used for assessment of interleukin (IL)-6, IL-1β, tumor necrosis factor-alpha (TNF-α), IL-10, Toll-like receptor 4 (TLR4), protein kinase B (AKT), phosphoinositide 3-kinases (PI3K), signal transducer and activator of transcription 3 (STAT3), and histopathological examination.
Findings/Results: Brain tissue levels of TNF-α, IL-6, and IL1 β were higher in the sepsis group than in the sham and vehicle groups. The dasatinib group had considerably lower tissue levels of these markers and significantly higher tissue values of IL-10 than the sepsis and vehicle groups. The sham group had much lower tissue values of TLR4, AKT, STAT3, and PI3k than in sepsis and vehicle groups. Furthermore, tissue levels of these markers in the dasatinib group were considerably lower than those in the sepsis and vehicle groups. Histopathology demonstrated that dasatinib might considerably reduce brain damage and the intensity of neuroinflammation when compared to sepsis and vehicle groups that showed extensive brain inflammation and damage.
Conclusion and implication: Dasatinib attenuated endotoxemia-induced acute brain damage in mice via modulating effects on TLR4, PI3K, AKT, and STAT3 downstream signaling pathways.Keywords
References
Hassan ES, Jawad AS, Mohammad AR. Protective effect of liraglutide from acute renal injury during endotoxemia in mice mode. Lat Am J Pharm. 2022;41(2):428-436.
Hussein SN, Majeed SA, Ghafil FA, Hassan ES, Abdulkadim H, Ghazi A, et al. Nephroprotective effect of celastrol in an experimental model of endotoxemia. Bull Nal Insti. 2022;140(6):2865-2874.
Jawad, AS, Hassan ES, Mohammad AR. Protective effect of empagliflozin from acute renal injury during endotoxemia in mice model. Lat Am J Pharm. 2022;41(2):463-471.
Hamza RT, Majeed SA, Ghafil FA, Hassan ES, Hadi NR. Nephroprotective effect of melatonin in sepsis induces renal injury : CLP mice model. Lat Am J Pharm. 2022, 41(3):589-596.
Mohammad AR, Hadi AR, Hassan ES. Potential protective effect of ibrutinib from acute brain injury during endotoxemia in mice. Lat Am J Pharm. 2022;41(2):472-480.
Lu H, Ai L, Zhang B. TNF-α induces AQP4 overexpression in astrocytes through the NF-κB pathway causing cellular edema and apoptosis. Biosci Rep. 2022;42(3):BSR20212224,1-13. DOI: 10.1042/BSR20212224
Hussein SN, Majeed SA, Ghafil FA, Hassan ES, Hadi NR. Toll-like receptors 4 antagonist, Ibudilast, ameliorates acute renal impairment induced by sepsis in an experimental model. Bull Nal Insti. 2022;140(7):2899-2909.
Semmler A, Hermann S, Mormann F, Webrpals M, Paxian SA, Okulla T, et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation, 2008;5:38,1-10. DOI: 10.1186/1742-2094-5-38.
Guerriero RM, Giza CC, Rotenberg A. Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep. 2015;15(5):27,1-11. DOI: 10.1007/s11910-015-0545-1.
Levêque D, Becker G, Bilger K, Natarajan-Amé S. Clinical pharmacokinetics and pharmacodynamics of dasatinib. Clin Pharmacokinet. 2020;59(7):849-856. DOI: 10.1007/s40262-020-00872-4.
Ryu KY, Lee HJ, Woo H, Kang RJ, Han KM, Park H, et al. Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling. J Neuroinflammation. 2019;16(1):190,1-36. DOI: 10.1186/s12974-019-1561-x.
Drosatos K, Khan RS, Trent CM, Jiang H, Son NH, Blaner WS, et al. Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice. Circ Heart Fail. 2013;6(3):550-562. DOI: 10.1161/CIRCHEARTFAILURE.112.000177.
Wellington D, Mikaelian I, Singer L. Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats. J Am Assoc Lab Anim Sci. 2013;52(4):481-487. PMID: 23849447.
Bolanle F, Yongshan M, Maria S, Modinat L, Hallenbeck J. Downstream Toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia. J Neuroinflammation. 2012;9:174,1-11. DOI: 10.1186/1742-2094-9-174.
Yousif NG, Hadi NR, Al-Amran F, Zigam QA. Cardioprotective effects of irbesartan in polymicrobial sepsis : the role of the p38MAPK/NF-κB signaling pathway. Herz. 2018;43(2):140-145. DOI: 10.1007/s00059-017-4537-6.
Chandrashekhar VM, Ranpariya VL, Ganapaty S, Parashar A, Muchandi AA. Neuroprotective activity of Matricaria recutita Linn against global model of ischemia in rats. J Ethnopharmacol. 2010;127(3):645-651. DOI: 10.1016/j.jep.2009.12.009.
Zahran R, Ghozy A, Elkholy SS, El-Taweel F, El-Magd MA. Combination therapy with melatonin, stem cells and extracellular vesicles is effective in limiting renal ischemia-reperfusion injury in a rat model. Int J Urol. 2020;27(11):1039-1049. DOI: 10.1111/iju.14345.
Rajarajan S, Anupama CE, Jose B, Correa M, Sengupta S, Prabhu JS. Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1. Mol Clin Oncol. 2020;13(5):57,1-8. DOI: 10.3892/mco.2020.2128.
Dellinger RP. The surviving sepsis campaign: 2013 and beyond. Chin Med J (Engl). 2013;126(10):1803-1855. PMID: 23673089.
Moraes CA, Zaverucha-do-Valle C, Fleurance R, Sharshar T, Bozza FA, d'Avila JC. Neuroinflammation in sepsis: molecular pathways of microglia activation. Pharmaceuticals (Basel). 2021;14(5):416,1-22.DOI: 10.3390/ph14050416.
Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787-1794. DOI: 10.1001/jama.2010.1553.
Kwon A, Kwak BO, Kim K, Ha J, Kim SJ, Bae SH, et al. Cytokine levels in febrile seizure patients: a systematic review and meta-analysis. Seizure. 2018;59:5-10. DOI: 10.1016/j.seizure.2018.04.023.
Cook AD, Christensen AD, Tewari D, McMahon SB, Hamilton JA. Immune cytokines and their receptors in inflammatory pain. Trends Immunol. 2018 Mar;39(3):240-255. DOI: 10.1016/j.it.2017.12.003.
Aldana BI. Microglia-specific metabolic changes in neurodegeneration. J Mol Biol. 2019;431(9): 1830-1842. DOI: 10.1016/j.jmb.2019.03.006.
Fu HQ, Yang T, Xiao W, Fan L, Wu Y, Terrando N, et al. Prolonged neuroinflammation after lipopolysaccharide exposure in aged rats. PLoS One. 2014;9(8):e106331,1-9.DOI: 10.1371/journal.pone.0106331.
Negrin LL, Jahn A, van Griensven M. Leptin protects against mortality and organ dysfunction in a two-hit trauma/sepsis model and is IL-6-dependent. Shock. 2017;48(1):130-137. DOI: 10.1097/SHK.0000000000000837.
Savran M, Aslankoc R, Ozmen O, Erzurumlu Y, Savas HB, Temel EN, et al. Agomelatine could prevent brain and cerebellum injury against LPS-induced neuroinflammation in rats. Cytokine. 2020;127:154957,1-9. DOI: 10.1016/j.cyto.2019.154957.
Guo K, Bu X, Yang C, Cao X, Bian H, Zhu Q, et al. Treatment effects of the second-generation tyrosine kinase inhibitor dasatinib on autoimmune arthritis. Front Immunol. 2019;9:3133,1-12. DOI: 10.3389/fimmu.2018.03133.
Hoogland ICM, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D. Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation. 2015;12:114,1-13. DOI: 10.1186/s12974-015-0332-6.
Karimy JK, Reeves BC, Kahle KT. Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury. Expert Opin Ther Targets. 2020;24(6): 525-533. DOI: 10.1080/14728222.2020.1752182.
Chen J, Lan T, Zhang W, Dong L, Kang N, Fu M, et al. Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways. Arch Biochem Biophys. 2015;575:38-45. DOI: 10.1016/j.abb.2014.11.008.
Azizi G, Goudarzvand M, Afraei S, Sedaghat R, Mirshafiey A. Therapeutic effects of dasatinib in mouse model of multiple sclerosis. Immunopharmacol Immunotoxicol. 2015;37(3): 287-294. DOI: 10.3109/08923973.2015.1028074.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.